| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| P50 | author | Alan J Wein | Q67190115 |
| P2093 | author name string | Ian Milsom | |
| Chieh-I Chen | |||
| Marion Kvasz | |||
| Sean Nicholson | |||
| Karin S. Coyne | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| urinary incontinence | Q281490 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 130-40 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Journal of Managed Care Pharmacy | Q15757065 |
| P1476 | title | Economic burden of urgency urinary incontinence in the United States: a systematic review | |
| P478 | volume | 20 |
| Q55245159 | 18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus. |
| Q47686428 | A cross-sectional study in the USA of the epidemiology and quality of life of underactive bladder symptoms |
| Q47172054 | A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence |
| Q47143545 | An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents. |
| Q37184223 | Basal and stress-activated hypothalamic pituitary adrenal axis function in postmenopausal women with overactive bladder |
| Q36925707 | Bladder Symptoms in the Early Menopausal Transition |
| Q26783536 | Clinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndrome |
| Q37127647 | Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity? |
| Q33743120 | Effect of sacrocolpopexy and retropubic sling on overactive bladder symptoms |
| Q93221050 | Effectiveness of an intervention to optimise the use of mirabegron for overactive bladder: a quasi-experimental study in primary care |
| Q58617423 | Effects of RSC96 Schwann Cell-Derived Exosomes on Proliferation, Senescence, and Apoptosis of Dorsal Root Ganglion Cells In Vitro |
| Q36027292 | Female urinary incontinence and wellbeing: results from a multi-national survey |
| Q26775914 | Implantable Bladder Sensors: A Methodological Review |
| Q38228516 | Management of refractory OAB in the non-neurogenic patient |
| Q88651607 | Multiparity, age and overweight/obesity as risk factors for urinary incontinence in pregnancy: a systematic review and meta-analysis |
| Q47760183 | Nerve-sparing Mid-urethral Obstruction (NeMO) in Female Small Rodents. |
| Q64091389 | New technologies in the management of overactive bladder: current research and future prospects |
| Q87844672 | Obesity and Stress Urinary Incontinence: Impact on Pathophysiology and Treatment |
| Q33587587 | OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial |
| Q35822811 | Physician Use of Sacral Neuromodulation Among Medicare Beneficiaries With Overactive Bladder and Urinary Retention |
| Q35180932 | Psychosomatic Aspects of Urinary Incontinence in Women |
| Q48261533 | Quality-of-Life Outcomes Following Surface Electromyography Biofeedback as an Adjunct to Pelvic Floor Muscle Training for Urinary Incontinence: A Case Report |
| Q57155065 | Quantitative Proteomic Analysis Reveals Caffeine-Perturbed Proteomic Profiles in Normal Bladder Epithelial Cells |
| Q38631505 | Radiotherapy is associated with reduced continence outcomes following implantation of the artificial urinary sphincter in men with post-radical prostatectomy incontinence. |
| Q89970131 | Randomized controlled trial for the efficacy of electroacupuncture in the treatment of urge urinary incontinence: A clinical study protocol |
| Q88564477 | Review of Economic Value Drivers of the Treatment of Overactive Bladder |
| Q28066372 | Sacral neuromodulation in overactive bladder: a review and current perspectives |
| Q37373376 | Social, Economic, and Medical Factors Associated With Solifenacin Therapy Compliance Among Workers Who Suffer From Lower Urinary Tract Symptoms. |
| Q43342017 | The Effect of Bariatric Surgery on Urinary Incontinence in Women |
| Q90475981 | The Effect of a Sharp Increase in Estrogen Levels on Overactive Bladder Symptoms in Women Undergoing Ovulation Induction |
| Q52596571 | The Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium: A Transdisciplinary Approach Toward Promoting Bladder Health and Preventing Lower Urinary Tract Symptoms in Women Across the Life Course. |
| Q36450134 | The Worldwide Economic Impact of Neurogenic Bladder |
| Q50128131 | The effect of pelvic pain and urinary incontinence on women's self-rated health in northern Mexico |
| Q38239522 | The evaluation and management of refractory neurogenic overactive bladder |
| Q34165475 | The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. |
| Q57824526 | The impact of age, gender and severity of overactive bladder wet on quality of life, productivity, treatment patterns and satisfaction |
| Q57295235 | The mysteries of menopause and urogynecologic health: clinical and scientific gaps |
| Q37461417 | Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial |
| Q38590670 | Treatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin |
| Q58736091 | Troubleshooting Interstim Sacral Neuromodulation Generators to Recover Function |
| Q47442547 | Ultrasound bladder wall thickness and detrusor overactivity: a multicentre test accuracy study |
| Q39439599 | Understanding the Economic Impact of Neurogenic Lower Urinary Tract Dysfunction |
| Q35928189 | Urinary Incontinence Before and After Bariatric Surgery. |
Search more.